Background/Aims: Familial glucocorticoid deficiency type 1 (FGD1) is a rare autosomal-recessive disorder resulting from defective ACTH receptor (melanocortin receptor type 2, MC2R). Individuals with this condition usually present in infancy or early childhood with the signs and symptoms of isolated glucocorticoid deficiency. To date, hypothyroidism has been reported as an associated feature in a few cases. The clinical findings along with MC2R genetic analysis of five Arab kindreds are described. Subjects/Methods: The subjects were children with the clinical and biochemical features of FGD1. Three patients had associated thyroid dysfunction and two patients had associated growth hormone deficiency (GHD). Mutation analysis of MC2R was performed by direct gene sequencing. Results: Analysis of the MC2R gene revealed a homozygous insertion of a cytosine nucleotide between codons 153 and 154 (c.459_460insC) in all of the patients. This mutation would be expected to cause a translation frame shift after codon 154 and a premature termination codon at 248 of the MC2R mRNA (p.I154fsX248). Conclusions: Associated thyroid dysfunction and GHD were clinical features in the Bedouin patients with FGD1 caused by identical homozygous frameshift mutation in the MC2R gene.

Keywords:
Familial glucocorticoid deficiency, ACTH resistance, Glucocorticoid deficiency, Hypothyroidism
1.
Clark AJL, Weber A: Adrenocorticotropin insensitivity syndromes. Endocr Rev 1998;19:828–843.
2.
Chan LF, Clark AJL, Metherell LA: Familial glucocorticoid deficiency: advances in the molecular understanding of ACTH action. Horm Res 2008;69:75–82.
3.
Lin L, Hindmarsh PC, Metherell LA, Alzyoud M, Al-Ali M, Brain CE, Clark AJL, Dattani MT, Achemann JC: Severe loss-of-function mutations in the adrenocorticotropin receptor (ACTHR, MC2R) can be found in patients diagnosed with salt-losing adrenal hypoplasia. Clin Endocrinol (Oxf) 2007;66:205–210.
4.
Chan LF, Metherell LA, Krude H, Ball C, O’Riodrdan SMP, Costigan C, Lynch SA, Savage MO, Cavarzere P, Clark AJL: Homozygous nonsense and frameshift mutations of the ACTH receptor in children with familial glucocorticoid deficiency (FGD) are not associated with long-term mineralocorticoid deficiency. Clin Endocrinol (Oxf) 2009;71:171–175.
5.
Clark AJL, Chan LF, Chung TT, Metherell AL: The genetics of familial glucocorticoid deficiency. Best Practice Res Clin Endocrinol Metab 2009;23:159–165.
6.
Metherell LA, Chapple PJ, Cooray S, David A, Becker C, Ruschendorf F, Naville D, Begeot M, Khoo B, Nurnberg P, Huebner A, Cheetham ME, Clark AJL: Mutations in MRAP, encoding a new interacting partner of ACTH receptor, cause familial glucocorticoid deficiency type 2. Nat Genet 2005;37:166–170.
7.
Genin E, Huebner A, Jaillard C, Faure A, Halaby G, Saka N, Clark AJL, Durand P, Pegeot M, Naville D: Linkage of one gene for familial glucocorticoid deficiency type 2 (FGD2) to chromosome 8q and further evidence of heterogeneity. Hum Genet 2002;111:428–434.
8.
Metherell LA, Naville D, Halaby G, Begeot M, Huebner A, Nürnberg G, Nürnberg P, Green J, Tomlinson JW, Krone NP, Lin L, Racine M, Berney DM, Achermann JC, Arlt W, Clark AJL: Nonclassic lipoid congenital adrenal hyperplasia masquerading as familial glucocorticoid deficiency. J Clin Endocrinol Metab 2009;94:3865–3871.
9.
O’Riordan SMP, Lynch SA, Hindmarsh PC, Chan LF, Clark AJL, Costigan C: A novel variant of familial glucocorticoid deficiency prevalent among the Irish Traveler population. J Clin Endocrinol Metab 2008;93:2896–2899.
10.
Chung TT, Chan LF, Metherell LA, Clark AJL: Phenotypic characteristics of familial glucocorticoid deficiency type 1 and 2. Clin Endocrinol (Oxf) 2010;72:589–594.
11.
Elias LLK, Huebner A, Pullinger GD, Mirtelle A, Clark AJL: Functional characterization of naturally occurring mutations of human adrenocorticotropin receptor: poor correlation of phenotype and genotype. J Clin Endocrinol Metab 1999;84:2766–2770.
12.
Tiosano D, Pannain S, Vassart G, Parma J, Gershoni-Baruch R, Mandel H, Lotan R, Zaharan Y, Pery M, Weiss RE, Refetoff S, Hochberg Z: The hypothyroidism in an inbred kindred with congenital thyroid hormone and glucocorticoid deficiency is due to a mutation producing a truncated thyrotropin receptor. Thyroid 1999;9:887–894.
13.
Goto M, Katsumata N: X-linked adrenal hypoplasia congenita caused by a novel intronic mutation of the DAX-1 gene. Horm Res 2009;71:120–124.
14.
Katsumata N, Tanae A, Shinagawa T, Nagashima-Miyokawa A, Shimizu M, Yasunaga T, Tanaka T, Hibi I: Detection of the missense mutation A218V in the steroidogenic acute regulatory protein gene in a Japanese patient with congenital lipoid adrenal hyperplasia. Clin Pediatr Endocrinol 1997;6:33–37.
15.
Katsumata N, Ohtake M, Hojo T, Ogawa E, Hara T, Sato N, Tanaka T: Compound heterozygous mutations in the cholesterol side-chain cleavage enzyme gene (CYP11A) cause congenital adrenal insufficiency in humans. J Clin Endocrinol Metab 2002;87:3808–3813.
16.
Clark AJL, McLoughlin L, Grossman A: Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor. Lancet 1993;341:461–462.
17.
Teebi AS: Autosomal recessive disorders among Arabs: an overview from Kuwait. J Med Genet 1994;31:224–233.
18.
Elias LLK, Huebner A, Metherell LA, Canas A, Warne GL, Bitti MLM, Cianfarani S, Clayton PE, Savage MO, Clark AJL: Tall stature in familial glucocorticoid deficiency. Clin Endocrinol (Oxf) 2000;53:423–430.
19.
Chida D, Nakagawa S, Nagai S, Sagara H, Katsumata H, Imaki T, Suzuki H, Mitani F, Ogishima T, Shimizu C, Kotaki H, Kakuta S, Sudo K, Koike T, Kubo M, Iwakura Y: Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis. Proc Natl Acad Sci USA 2007;104:18205–18210.
20.
Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV: Serum ferritin: past, present and future. Biochim Biophys Acta 2010;1800:760–769.
21.
Imamine H, Mizuno H, Sugiyama Y, Ohro Y, Sugiura T, Togari H: Possible relationship between elevated plasma ACTH and tall stature in familial glucocorticoid deficiency. Tohoku J Exp Med 2005;205:123–131.
22.
Zhong Q, Sridhar S, Ruan L, Ding KH, Xie D, Insogna K, Kang B, Xu J, Bollag RJ, Isales CM: Multiple melanocortin receptors are expressed in bone cells. Bone 2005;36:820–831.
23.
Per H, Kumandas S, Coskun A, Gumus H, Oztop D: Neurological sequalae of neonatal hypoglycemia in Kayseri, Turkey. J Child Neurol 2008;231:1406–1412.
24.
Duvanel CB, Fawer CL, Cotting J, Hohlfeld P, Mattiew JM: Long-term effects of neonatal hypoglycemia on brain growth and psychomotor development in small-for-gestational age preterm infants. J Pediatr 1999;134:492–498.
25.
Xu NY, Chen XQ, Du JZ, Wang TY, Duan C: Intermittent hypoxia causes a suppressed pituitary growth hormone through somatostatin. Neuroendocrinol Lett 2004;25:361–367.
26.
Barnet AH, Donald RA, Espiner EA: High concentration of thyroid-stimulating hormone in untreated glucocorticoid deficiency: indication of primary hypothyroidism? BMJ 1982;285:172–173.
27.
Wilber JF, Utiger RD: The effect of glucocorticoid on thyrotropin secretion. J Clin Invest 1969;48:2096–2103.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.